Prescribe via the SAS-B Pathway for Doctors

$39.00

Unit price: per

Overview

While medical cannabis is an effective treatment option for many patients, it’s considered an unapproved good on the TGA’s schedule of drugs. This course is designed to equip healthcare professionals with the skills, knowledge and confidence to navigate the TGA’s Special Access Scheme (SAS) and apply to prescribe medical cannabis to suitable individual patients on a case by case basis using the SAS-B pathway.
We’ll also delve into the broader legal and ethical considerations of prescribing medical cannabis as a treatment option, including risk-mitigation strategies so you can start prescribing medical cannabis to your eligible patients as soon as possible.
Preview this course by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this course, you’ll be able to:
Define unapproved good
Describe different pathways for accessing and prescribing unapproved goods
Explain the differences and correct use of the SAS and Authorised prescriber pathways
Apply to prescribe medical cannabis for individual patients using the SAS-B pathway
Explain the legal and ethical considerations, and risk-mitigation strategies when prescribing medical cannabis via the SAS-B pathway
To access this resource, please complete your purchase. Once purchased, the resource will be available in your learning portal.
The topics explored within each module of this course are outlined below.
Module 1: Introduction
How to navigate and complete the course successfully
Introduce Kai and Zahir as case studies
Module 2: Access Unapproved Goods
The Australian Register of Therapeutic Goods (ARTG)
Classification of approved, exempt and unapproved goods as per the ARTG system
How to identify and access approved and unapproved goods
The different pathways to access unapproved goods – their purpose, similarities and differences
When to use the Special Access Scheme (SAS)-B pathway instead of SAS-A or SAS-C
Module 3: Risks, Legalities and Appropriate Use
Appropriate use of the SAS-B pathway
Identification of necessary information to assess patient suitability for medical cannabis treatment in terms of safety and effectiveness
Risks associated with prescribing unapproved medications
Informed consent in the context of medical cannabis treatment
Scheduling of Medical Cannabis in Australia
Legislative requirements (including state/territory based requirements)
Medico-legal and indemnity risks of prescribing medical cannabis
Reporting requirements for medical cannabis prescribers
Prescribers’ obligations to provide access to medical cannabis
This learning activity is equivalent to 1 CPD via the EDUCATIONAL ACTIVITIES pathway.

We have included a complimentary, pre-filled CPD recording template. Learners who wish to claim CPD credits upon completion of this activity may complete this template and submit it to their relevant CPD home or accrediting body for CPD recognition.

ABOUT THIS RESOURCE

Overview

While medical cannabis is an effective treatment option for many patients, it’s considered an unapproved good on the TGA’s schedule of drugs. This course is designed to equip healthcare professionals with the skills, knowledge and confidence to navigate the TGA’s Special Access Scheme (SAS) and apply to prescribe medical cannabis to suitable individual patients on a case by case basis using the SAS-B pathway.

We’ll also delve into the broader legal and ethical considerations of prescribing medical cannabis as a treatment option, including risk-mitigation strategies so you can start prescribing medical cannabis to your eligible patients as soon as possible.

Preview this course by watching the video above.

Estimated Duration: 1 hour

Access Duration: 12 months from date of purchase

Learning Outcomes

Upon completion of this course, you’ll be able to:

Define unapproved good
Describe different pathways for accessing and prescribing unapproved goods
Explain the differences and correct use of the SAS and Authorised prescriber pathways
Apply to prescribe medical cannabis for individual patients using the SAS-B pathway
Explain the legal and ethical considerations, and risk-mitigation strategies when prescribing medical cannabis via the SAS-B pathway

Your cart

Your cart is empty

Prescribe via the SAS-B Pathway for Doctors

Customer reviews

Overview

Learning Outcomes

Module 1: Introduction

Module 2: Access Unapproved Goods

Module 3: Risks, Legalities and Appropriate Use

This learning activity is equivalent to 1 CPD via the EDUCATIONAL ACTIVITIES pathway.

ABOUT THIS RESOURCE

Overview

Learning Outcomes

HOW TO ACCESS

MODULE CONTENTS

Module 1: Introduction

Module 2: Access Unapproved Goods

Module 3: Risks, Legalities and Appropriate Use

CPD INFORMATION

This learning activity is equivalent to 1 CPD via the EDUCATIONAL ACTIVITIES pathway.

Recommended products

Recently viewed

Availability